Zobrazeno 1 - 10
of 280
pro vyhledávání: '"O.N. Tkacheva"'
Autor:
A.S. Kruglikova, I.D. Strazhesko, E.V. Plokhova, V.S. Pyhtina, D.U. Akasheva, O.U. Isaykina, O.N. Tkacheva, S.A. Boytsov
Publikováno v:
Artery Research, Vol 7, Iss 10 (2013)
Objective: Telomere length (TL) has been identified as a marker for biological, cardiovascular aging and cardiovascular events risk. Increased arterial stiffness and intima-media thickness (IMT) are the main signs of arterial aging and strong predict
Externí odkaz:
https://doaj.org/article/1617b5546aac40a59776a62d87980b5c
Autor:
I.S. Strazhesko, O.N. Tkacheva, D.U. Akasheva, A.S. Kruglikova, E.V. Plokhova, O.U. Isaykina, M.S. Poktovskaya, V.A. Vygodin, V.S. Pykhtina, S.A. Boytsov
Publikováno v:
Artery Research, Vol 7, Iss 10 (2013)
Objectives: Increased arterial stiffness (AS) is the most prominent feature of arterial aging. It has been shown an association of AS not only with age, but also with insulin resistance (IR). Leukocyte telomere length (TL) has been proposed as an ind
Externí odkaz:
https://doaj.org/article/d3587214503d43dfb8cf911ed890d31d
Autor:
E.N. Dudinskaya, N.V. Brailova, I.D. Strazhesko, O.Y. Isaikina, M.S. Pokrovskaya, O.N. Tkacheva, S.A. Boytsov, M.V. Shestakova
Publikováno v:
Artery Research, Vol 7, Iss 10 (2013)
It is known that telomere length (TL) shortening is a marker of cell aging, which accelerated and progresses in type 2 diabetes mellitus (T2DM), despite the patient’s age, leading to the vascular aging. The aim of the study was to compare the vasc
Externí odkaz:
https://doaj.org/article/e67f619992cf4335bb8f4a29ba9dc998
Autor:
O.N. Tkacheva, Andrey V. Dekhnich, Andrey A. Zaitsev, S.M. Harit, V.P. Chulanov, Sergey Avdeev, Svetlana Rachina, A. I. Sinopal’nikov, T.V. Nikonova, G. R. Galstyan, Roman S. Kozlov, Nikolay Ivanovich Briko, L.Y. Drozdova, Sergey Sidorenko
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 23, Iss 2, Pp 161-165 (2021)
The purpose of the meeting is to obtain an opinion on approaches and recommendations for vaccine prevention of pneumococcal infections in adults.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b15064d822fb6e9486c5ec41e8aad701
https://cmac-journal.ru/publication/2021/2/cmac-2021-t23-n2-p161/cmac-2021-t23-n2-p161.pdf
https://cmac-journal.ru/publication/2021/2/cmac-2021-t23-n2-p161/cmac-2021-t23-n2-p161.pdf
Autor:
A.N. Bogolepova, E.V. Brovko, S.I. Gavrilova, M.V. Gantman, R.O. Dreval, S.N. Illarioshkin, E.A. Katunina, C. Konson, G.P. Kostjuk, J.V. Kotovskaja, O.S. Levin, I.V. Litvinenko, V.E. Medvedev, E.A. Mkhitarjan, N.G. Neznanov, E.J. Onegina, V.A. Parfenov, O.N. Tkacheva, E.J. Fedotova, A.L. Shchetkina, N.N. Yakhno
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 122(7)
The care of a patient with Alzheimer's disease (AD) is considered from the perspective of an ecosystem, that is, a systemic approach describing effective partnership, collaboration and research aimed at creating value, involving all participants in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb23f87546a990611cc46e4e21e82a3c
https://pubmed.ncbi.nlm.nih.gov/35904303
https://pubmed.ncbi.nlm.nih.gov/35904303
Publikováno v:
Yakut Medical Journal. :35-38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbaf1a1f1be0eef782bcdaeee2e49d82
https://doi.org/10.25789/ymj.2021.74.09
https://doi.org/10.25789/ymj.2021.74.09
Publikováno v:
Pharmateca. :65-74
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96d70b27267e7344437c8704068e84ac
https://doi.org/10.18565/pharmateca.2020.13.65-74
https://doi.org/10.18565/pharmateca.2020.13.65-74
Autor:
E.A. Bryushkova, V.D. Skatova, Z.Y. Mutovina, A.I. Zagrebneva, D.S. Fomina, T.S. Kruglova, A. Akopyan, I.D. Strazhesko, S. Lukyanov, O.N. Tkacheva, M.A. Lysenko, D.M. Chudakov
BackgroundThe aim of the study was to assess inflammatory markers and clinical outcomes in adult patients admitted to hospital with mild-to-moderate COVID-19 and treated with targeted immunosuppressive therapy using anti-IL-17A (netakimab), anti-IL-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc8e63eb5e973a61618ef225e296a378
https://doi.org/10.1101/2022.03.31.22269942
https://doi.org/10.1101/2022.03.31.22269942
Publikováno v:
Therapy. :206-220
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b6f00ceabbf2028efb8739b4677a04d
https://doi.org/10.18565/therapy.2020.5.206-220
https://doi.org/10.18565/therapy.2020.5.206-220
Autor:
Kotovskaya Yu.V. Kotovskaya, Efremkin I.V. Efremkin, Zolozov S.V. Zolozov, Dubov A.A. Dubov, Darmaeva I.P. Darmaeva, Kokorin V.A. Kokorin, Russian Clinical, Naumov A.V. Naumov, Sharashkina N.V. Sharashkina, Onuchina Yu.S. Onuchina, Tkacheva O.N. Tkacheva, Shirin D.A. Shirin, Lobachev E.V. Lobachev, Milto A.S. Milto, Kosmynin V.S. Kosmynin, Manevich T.M. Manevich, Mandrygina E.L. Mandrygina
Publikováno v:
Therapy. :47-55
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8b70f32aef815eef62eece366ab6bf2
https://doi.org/10.18565/therapy.2020.5.47-55
https://doi.org/10.18565/therapy.2020.5.47-55